Copyright Reports & Markets. All rights reserved.

Global OAB Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global OAB Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Anticholinergics
      • 1.4.3 Mirabegron
      • 1.4.4 Botox
    • 1.5 Market by Application
      • 1.5.1 Global OAB Treatment Market Share by Application (2019-2025)
      • 1.5.2 Idiopathic Overactive Bladder
      • 1.5.3 Neurogenic Overactive Bladder
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 OAB Treatment Market Size
    • 2.2 OAB Treatment Growth Trends by Regions
      • 2.2.1 OAB Treatment Market Size by Regions (2019-2025)
      • 2.2.2 OAB Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 OAB Treatment Market Size by by Players
      • 3.1.1 Global OAB Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global OAB Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global OAB Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 OAB Treatment Key Players Head office and Area Served
    • 3.3 Key Players OAB Treatment Product/Solution/Service
    • 3.4 Date of Enter into OAB Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global OAB Treatment Market Size by Type (2014-2019)
    • 4.2 Global OAB Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America OAB Treatment Market Size (2014-2019)
    • 5.2 OAB Treatment Key Players in North America
    • 5.3 North America OAB Treatment Market Size by Type
    • 5.4 North America OAB Treatment Market Size by Application

    6 Europe

    • 6.1 Europe OAB Treatment Market Size (2014-2019)
    • 6.2 OAB Treatment Key Players in Europe
    • 6.3 Europe OAB Treatment Market Size by Type
    • 6.4 Europe OAB Treatment Market Size by Application

    7 China

    • 7.1 China OAB Treatment Market Size (2014-2019)
    • 7.2 OAB Treatment Key Players in China
    • 7.3 China OAB Treatment Market Size by Type
    • 7.4 China OAB Treatment Market Size by Application

    8 Japan

    • 8.1 Japan OAB Treatment Market Size (2014-2019)
    • 8.2 OAB Treatment Key Players in Japan
    • 8.3 Japan OAB Treatment Market Size by Type
    • 8.4 Japan OAB Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia OAB Treatment Market Size (2014-2019)
    • 9.2 OAB Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia OAB Treatment Market Size by Type
    • 9.4 Southeast Asia OAB Treatment Market Size by Application

    10 India

    • 10.1 India OAB Treatment Market Size (2014-2019)
    • 10.2 OAB Treatment Key Players in India
    • 10.3 India OAB Treatment Market Size by Type
    • 10.4 India OAB Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America OAB Treatment Market Size (2014-2019)
    • 11.2 OAB Treatment Key Players in Central & South America
    • 11.3 Central & South America OAB Treatment Market Size by Type
    • 11.4 Central & South America OAB Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Astellas Pharma
      • 12.1.1 Astellas Pharma Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 OAB Treatment Introduction
      • 12.1.4 Astellas Pharma Revenue in OAB Treatment Business (2014-2019))
      • 12.1.5 Astellas Pharma Recent Development
    • 12.2 Allergan
      • 12.2.1 Allergan Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 OAB Treatment Introduction
      • 12.2.4 Allergan Revenue in OAB Treatment Business (2014-2019)
      • 12.2.5 Allergan Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 OAB Treatment Introduction
      • 12.3.4 Pfizer Revenue in OAB Treatment Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Teva (Activas)
      • 12.4.1 Teva (Activas) Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 OAB Treatment Introduction
      • 12.4.4 Teva (Activas) Revenue in OAB Treatment Business (2014-2019)
      • 12.4.5 Teva (Activas) Recent Development
    • 12.5 Johnson & Johnson
      • 12.5.1 Johnson & Johnson Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 OAB Treatment Introduction
      • 12.5.4 Johnson & Johnson Revenue in OAB Treatment Business (2014-2019)
      • 12.5.5 Johnson & Johnson Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global OAB Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the OAB Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Astellas Pharma
      Allergan
      Pfizer
      Teva (Activas)
      Johnson & Johnson
      ...

      Market segment by Type, the product can be split into
      Anticholinergics
      Mirabegron
      Botox

      Market segment by Application, split into
      Idiopathic Overactive Bladder
      Neurogenic Overactive Bladder

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global OAB Treatment status, future forecast, growth opportunity, key market and key players.
      To present the OAB Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of OAB Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now